J9032 Injection, belinostat, 10mg
Also known as: belinostat, Beleodaq
Intravenous injection of belinostat, a histone deacetylase inhibitor chemotherapy agent, dosed at 10 milligrams.
In Plain Language
protein-modifying cancer drug; epigenetic therapy
Clinical Context
Approved for relapsed or refractory peripheral T-cell lymphomas. Works by inhibiting histone deacetylase and inducing cell cycle arrest and apoptosis.
RVU Information
CPT J9032 does not have a physician work RVU assigned by CMS. This is typical for supply, drug, and equipment codes — reimbursement is based on Average Sales Price (ASP), fee schedules, or payer contracts rather than the RVU system.
Billing & Documentation
J-codes represent drugs administered by a healthcare provider (not self-administered). Documentation must include the drug name, dosage, route of administration, and medical necessity. Most payers require the National Drug Code (NDC) on the claim. Bill the appropriate administration code (96365-96379) in addition to the drug code.
Specialties
Frequently Asked Questions
What is CPT code J9032?
CPT J9032 (Injection, belinostat, 10mg) is a J Codes (Drugs) code. Intravenous injection of belinostat, a histone deacetylase inhibitor chemotherapy agent, dosed at 10 milligrams.
How is J9032 administered?
CPT J9032 is administered by a healthcare provider, typically via injection or infusion. Approved for relapsed or refractory peripheral T-cell lymphomas. Works by inhibiting histone deacetylase and inducing cell cycle arrest and apoptosis. It is used by Hematology/Oncology, Medical Oncology.
When is CPT J9032 used?
Approved for relapsed or refractory peripheral T-cell lymphomas. Works by inhibiting histone deacetylase and inducing cell cycle arrest and apoptosis.
Track This Code in RVU Edge
Log procedures, calculate wRVUs, and benchmark against MGMA data — all in one app.
CPT® is a registered trademark of the American Medical Association. Data sourced from CMS Physician Fee Schedule RVU26A. Descriptions, synonyms, and clinical context are original content by RVU Edge.